Skip to main content

Advertisement

Log in

Etanercept tolerance in a patient with previous infliximab-induced hepatitis

  • Letter to the Editor
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Harada K, Akai Y, Koyama S, Ikenaka Y, Saito Y (2008) A case of autoimmune hepatitis exacerbated by the administration of etanercept in a patient with rheumatoid arthritis. Clin Rheumatol 27:1063–1066

    Article  PubMed  Google Scholar 

  2. Tobon GJ, Canas C, Jaller J-J, Restrepo J-C, Anaya J-M (2007) Serious liver disease induced by infliximab. Clin Rheumatol 26:578–581

    Article  PubMed  Google Scholar 

  3. Goldenberg G, Jorizzo JL (2005) Use of etanercept in treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis. J Dermatolog Treat 16:347–349

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest statement

H.B. has received support for a research project from Essex. P.W. spoke at a symposium sponsored by Wyeth. M.G. spoke at symposia sponsored by and served on scientific boards for Essex and Wyeth. W.D. declares no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Heidemarie Becker.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Becker, H., Willeke, P., Domschke, W. et al. Etanercept tolerance in a patient with previous infliximab-induced hepatitis. Clin Rheumatol 27, 1597–1598 (2008). https://doi.org/10.1007/s10067-008-1000-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-008-1000-3

Keywords

Navigation